A phase III, multi-country, randomized, placebo-controlled, double-blinded adaptive platform trial to assess the efficacy and safety of treatments for participants with monkeypox virus disease

Authors
Category Primary study
Registry of TrialsPan African Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: d024bcaf5b5383bc77fed3c94485be67ae0bd834
First added on: Apr 11, 2025